Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2α phosphorylation in prostate cancer

Chunyi Zhang1, Mingming Zhang1, Qingyu Wu2

  • 1Gene Research Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.

Cellular Signalling
|January 11, 2015
PubMed

Insights

Hepsin, a protein overexpressed in prostate cancer (PCa), inhibits cell cycle progression by suppressing CDK11p58 expression. This occurs through regulating translation machinery, impacting cell survival in PCa.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Hepsin is a type II transmembrane serine protease.
  • Hepsin is frequently overexpressed in prostate cancer (PCa).
  • The precise role of hepsin in PCa pathogenesis is not fully understood.

Purpose of the Study:

  • To elucidate the function of hepsin in prostate cancer.
  • To investigate the molecular mechanisms by which hepsin influences PCa cell behavior.

Main Methods:

  • Investigated hepsin's effect on CDK11p58 expression via internal ribosome entry site (IRES) activity.
  • Analyzed the modulation of unr expression and eIF-2α phosphorylation by hepsin.
  • Examined hepsin's interaction with the unr IRES element and its impact on GCN2 signaling.

Main Results:

  • Hepsin was found to inhibit CDK11p58 IRES activity and expression in PCa cells.
  • Hepsin suppressed CDK11p58 IRES activity by modulating unr expression and eIF-2α phosphorylation.
  • Hepsin inhibited unr expression by binding to its IRES element and repressed eIF-2α phosphorylation via GCN2 pathway regulation.

Conclusions:

  • Hepsin plays a novel role in regulating CDK11p58 IRES activity in prostate cancer.
  • Hepsin may influence PCa cell cycle progression and survival by targeting translational machinery.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
7.1K